Kiniksa Pharmaceuticals International Insider Sold Shares Worth $9,625,790, According to a Recent SEC Filing

10:17 AM EST, 11/04/2026 (MT Newswires) -- Ross Moat, Chief Operating Officer, on October 30, 2026, sold 103,585 shares in Kiniksa Pharmaceuticals International (KNSA) for $9,625,790. Following the Form 4 filing with the SEC, Moat has control over a total of 10,294 Class A ordinary shares of the company, with 10,294 shares held directly. Sales were effected pursuant to a 10b5-1 plan executed on July 29. SEC Filing: https://www.sec.gov/Archives/edgar/data/1730430/000185717726000010/xslF345X05/form4-11032026_111116.xml Price: 93.66, Change: +0.37, Percent Change: +0.40